Soleno Therapeutics (SLNO) Free Cash Flow: 2013-2019
Historic Free Cash Flow for Soleno Therapeutics (SLNO) over the last 6 years, with Dec 2019 value amounting to -$5.1 million.
- Soleno Therapeutics' Free Cash Flow fell 35.93% to -$5.1 million in Q4 2019 from the same period last year, while for Dec 2019 it was -$17.4 million, marking a year-over-year decrease of 48.81%. This contributed to the annual value of -$69.3 million for FY2024, which is 177.94% down from last year.
- Per Soleno Therapeutics' latest filing, its Free Cash Flow stood at -$5.1 million for Q4 2019, which was down 7.67% from -$4.7 million recorded in Q3 2019.
- Over the past 5 years, Soleno Therapeutics' Free Cash Flow peaked at -$1.8 million during Q1 2015, and registered a low of -$5.1 million during Q4 2019.
- For the 3-year period, Soleno Therapeutics' Free Cash Flow averaged around -$3.3 million, with its median value being -$2.9 million (2017).
- Per our database at Business Quant, Soleno Therapeutics' Free Cash Flow slumped by 255.60% in 2015 and then soared by 45.37% in 2017.
- Quarterly analysis of 5 years shows Soleno Therapeutics' Free Cash Flow stood at -$3.1 million in 2015, then grew by 14.43% to -$2.7 million in 2016, then declined by 1.87% to -$2.7 million in 2017, then tumbled by 36.82% to -$3.7 million in 2018, then slumped by 35.93% to -$5.1 million in 2019.
- Its Free Cash Flow was -$5.1 million in Q4 2019, compared to -$4.7 million in Q3 2019 and -$3.9 million in Q2 2019.